Novel monitoring technique to minimise the risk for patients participating in pilot studies of investigational compounds

Por Cuffe, R, Ait-Khaled, M, Hughes, S, Min, S, Nichols, G, Thomas, D, Underwood, M, Yeo, JM
Publicado em 2010

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

Por Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait-Khaled, M, Min, S, Yeo, JM
Publicado em 2010

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3

Por Nichols, G, Mills, A, Grossberg, R, Lazzarin, A, Maggiolo, F, Molina, J, Pialoux, G, Wright, D, Ait-Khaled, M, Huang, J, Vavro, C, Wynne, B, Yeo, J
Publicado em 2012

Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status.

Por Lyall, E. G., Stainsby, C., Taylor, G. P., Ait-Khaled, M., Bingham, S., Evans, J. A., Wright, A., Weber, J. N., McClure, M. O., Walters, S., Tudor-Williams, G.
Publicado em 1998